[Federal Register Volume 86, Number 190 (Tuesday, October 5, 2021)]
[Notices]
[Page 54923]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-21655]


-----------------------------------------------------------------------

DEPARTMENT OF COMMERCE

Foreign-Trade Zones Board

[B-67-2021]


Foreign-Trade Zone (FTZ) 7--Mayaguez, Puerto Rico, Notification 
of Proposed Production Activity, AbbVie Ltd. (Pharmaceutical Products), 
Barceloneta, Puerto Rico

    AbbVie Ltd. (AbbVie) submitted a notification of proposed 
production activity to the FTZ Board (the Board) for its facility in 
Barceloneta, Puerto Rico within Subzone 7I. The notification conforming 
to the requirements of the Board's regulations (15 CFR 400.22) was 
received on September 24, 2021.
    Pursuant to 15 CFR 400.14(b), FTZ production activity would be 
limited to the specific foreign-status materials and specific finished 
products described in the submitted notification (summarized below) and 
subsequently authorized by the Board. The benefits that may stem from 
conducting production activity under FTZ procedures are explained in 
the background section of the Board's website--accessible via 
www.trade.gov/ftz. The proposed finished products and materials would 
be added to the production authority that the Board previously approved 
for the operation, as reflected on the Board's website.
    The proposed finished products include UBRELVY[supreg] tablets, 
ATOGEPANT[supreg] tablets and atogepant and ubrelvy extrudates (duty-
free).
    The proposed foreign-status materials include ubrogepant and 
atogepant active pharmaceutical ingredients (duty rate 6.5%). The 
request indicates both materials are subject to duties under section 
301 of the Trade Act of 1974 (section 301), depending on the country of 
origin. The applicable Section 301 decisions require subject 
merchandise to be admitted to FTZs in privileged foreign status (19 CFR 
146.41).
    Public comment is invited from interested parties. Submissions 
shall be addressed to the Board's Executive Secretary and sent to: 
[email protected]. The closing period for their receipt is November 15, 
2021.
    A copy of the notification will be available for public inspection 
in the ``Online FTZ Information System'' section of the Board's 
website.
    For further information, contact Christopher Wedderburn at 
[email protected].

    Dated: September 30, 2021.
Andrew McGilvray,
Executive Secretary.
[FR Doc. 2021-21655 Filed 10-4-21; 8:45 am]
BILLING CODE 3510-DS-P